nach oben

Die Gynäkologie

Erschienen in:

01.01.2009 | Frauengesundheit in der Praxis

Blutungen während Schwangerschaft und Geburt

Schwangerschaftsbedingte hämostaseologische Veränderungen – Therapieempfehlungen

verfasst von: Dr. S. Hofer, B. Heindl, F.C. Meister, H. Maul, E. Martin, C. Sohn, M.A. Weigand

Erschienen in: Die Gynäkologie | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Zusammenfassung

Blutungen während der Schwangerschaft sind für Mutter und Kind vital bedrohlich und verlaufen oft fulminant. Sie sind für etwa 25% aller peripartalen maternalen Sterbefälle verantwortlich. Die besondere Pathophysiologie der schwangerschaftsbedingten hämostaseologischen Veränderungen, wie das erhöhte Gerinnungspotenzial, eine verminderte antikoagulatorische Aktivität und starke Alterationen des fibrinolytischen Systems müssen dem interdisziplinären Behandlungsteam bekannt sein, um eine zielgerichtete und konsequente Therapie durchführen zu können.

Zu den wichtigsten therapeutischen Eckpfeilern bei peripartalen Blutungen zählen neben der schnellen zielgerichteten interdisziplinären Therapie die kausale gynäkologischen Therapie, die frühzeitige Detektion und Durchbrechung einer Hyperfibrinolyse, die Optimierung von Fibrinogen und Thrombozyten als Endstrecke der Gerinnung und die Kenntnis der Möglichkeiten einer erweiterten Gerinnungstherapie.

Alkazaleh F, Geary M, Kingdom J et al. (2004) Elective non-removal of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: a case report. J Obstet Gynaecol Can 26(8): 743–746PubMed

American Society of Anesthesiologists Task Force on Obstetric Anesthesia (2007) Practice guidelines for obstetric anesthesia: an updated report by the american society of anesthesiologists task force on obstetric anesthesia. Anesthesiology 106(4): 843–863CrossRef

Ananth CV, Savitz DA (1994) Vaginal bleeding and adverse reproductive outcomes: a meta-analysis. Paediatr Perinat Epidemiol 8(1): 62–78PubMedCrossRef

Astermark J, Donfield SM, DiMichele DM et al. (2007) FENOC study group. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA novoseven comparative (FENOC) study. Blood 109(2): 546–551PubMedCrossRef

Axelsen SM, Henriksen TB, Hedegaard M, Secher NJ (1995) Characteristics of vaginal bleeding during pregnancy. Eur J Obstet Gynecol Reprod Biol 63(2): 131–134PubMedCrossRef

Biron-Andreani C, Morau E, Schved JF (2003) Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb 33(3): 170–171PubMedCrossRef

Bonn C, Wetzka B, Zahradnik HP (2002) The use of TEG with the roTEG in preeclampsia and HELLP syndrome. Hypertens Pregnancy vol 21(suppl 1): 80

Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16(2): 153–168 ReviewPubMedCrossRef

Butt K, Gagnon A, Delisle MF (2002) Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol 99(6): 981–982PubMedCrossRef

10.

Catena C, Zingaro L, Casaccio D, Sechi LA (2000) Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 109(7): 556–561PubMedCrossRef

11.

Charbit B, Mandelbrot L, Samain E et al. (2007) PPH Study group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5(2): 266–273PubMedCrossRef

12.

Chowdhury P, Saayman AG, Paulus U et al. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125(1): 69–73PubMedCrossRef

13.

Clenney TL, Viera AJ (2004) Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ 329(7460): 270–272 reviewPubMedCrossRef

14.

Collins PW (2003) Management of acquired haemophilia A--more questions than answers. Blood Coagul Fibrinolysis. 14(Suppl 1): S23–S27 review

15.

Crochetiere C (2003) Obstetric emergencies. Anesthesiol Clin North America 21(1): 111–125 ReviewPubMedCrossRef

16.

Deneux-Tharaux C, Carmona E, Bouvier-Colle MH, Bréart G (2006) Postpartum maternal mortality and cesarean delivery. Obste Gynecol 541 vol 108, no3 part1

17.

Dildy GA (2002) Postpartum hemorrhage: new management options. Clin Obstet Gynecol 45(2): 330–344PubMedCrossRef

18.

Eder AF, Herron R, Strupp A et al. (2007) Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the american red cross. Transfusion 47(4): 599–607PubMedCrossRef

19.

FitzGerald MP, Floro C, Siegel J, Hernandez E (1996) Laboratory findings in hypertensive disorders of pregnancy. J Natl Med Assoc 88(12): 794–798PubMed

20.

Fonseca JE, Mendez F, Catano C, Arias F (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193(5): 1591–1598PubMedCrossRef

21.

Franchini M (2006) Postpartum acquired factor VIII inhibitors. Am J Hematol 81(10): 768–773PubMedCrossRef

22.

Franchini M, Lippi G, Franchi M (2007) The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 114(1): 8–15 reviewPubMedCrossRef

23.

Fuchs AR, Romero R, Keefe D et al. (1991) Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165: 1515–1523PubMed

24.

Gai MY, Wu LF, Su QF, Tatsumoto K (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112(2): 154–157PubMedCrossRef

25.

Gerbasi FR, Bottoms S, Farag A, Mammen E (1990) Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 75 (3 Pt 1): 385–389PubMed

26.

Goldszmidt E, Davies S (2003) Two cases of hemorrhage secondary to amniotic fluid embolus managed with uterine artery embolization. Can J Anaesth 50(9): 917–921PubMed

27.

Green D (2006) The management of acquired haemophilia. Haemophilia 12(Suppl 5): 32–36CrossRef

28.

Hansch E, Chitkara U, McAlpine J et al. (1999) Pelvic arterial embolization for control of obstetric hemorrhage:a five-year experience. Am J Obstet Gynecol 180: 1454–1460PubMedCrossRef

29.

Hardy JF, de Moerloose P, Samama CM (2006) Members of the groupe d’Interet en hemostase perioperatoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 53(suppl 6): S40–S58PubMedCrossRef

30.

Hatzopoulos FK (2005) Obstetric drug therapy. In: Koda-Kimble MA, Young LY, Kradjan WA et al. (eds) Applied therapeutics: the clinical use of drugs, 8th edn. Lippincott Williams & Wilkins, Philadelphia

31.

Hay CR, Brown S, Collins PW et al. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom haemophilia centre doctors organisation. Br J Haematol 133(6): 591–605PubMedCrossRef

32.

Heilmann L, Wild C, Hojnacki B, Pollow K (2006) Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII. Clin Appl Thromb Hemost 12(2): 227–229PubMedCrossRef

33.

Heindl B, Delorenzo C, Spannagl M (2005) High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 54(8): 787–790PubMedCrossRef

34.

Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29(2): 125–130 ReviewPubMedCrossRef

35.

Henrich W, Surbek D, Kainer F et al. (2008) Diagnosis and treatment of peripartum bleeding. J Perinat Med 10

36.

Henrich W, Fuchs I, Ehrenstein T et al. (2002) Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV. Ultrasound Obstet Gynecol 20(1): 90–93PubMedCrossRef

37.

Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33(Pt 2): 428–432 reviewPubMedCrossRef

38.

Holmes VA (2003) Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc 62(2): 479–493 reviewPubMedCrossRef

39.

Huch A, Chaoui R (2004) Sectio caesarea: In: Schneider H, Husslein P, Schneider KTM (Hrsg) Die Geburtshilfe, 2. Aufl. Springer, Berlin Heidelberg New York

40.

Innerhofer P, Fries D, Margreiter J et al. (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95(4): 858–865PubMedCrossRef

41.

Kam PC, Thompson SA, Liew AC (2004) Thrombocytopenia in the parturient. Anaesthesia 59(3): 255–264 reviewPubMedCrossRef

42.

Karalapillai D, Popham P (2007) Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 16(1): 29–34PubMedCrossRef

43.

Kobayashi T, Terao T, Maki M, Ikenoue T (2001) Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 27(2): 161–167 reviewPubMedCrossRef

44.

Koscielny J, von Tempelhoff GF, Ziemer S et al. (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10(2): 155–166PubMedCrossRef

45.

Kretzschmar M, Zahm DM, Rem ml er K et al. (2003) Anaphylactoid syndrome of pregnancy Pathophysiologische und therapeutische Aspekte der Fruchtwasserembolie (anaphylactoid syndrome of pregnancy) anhand einer Kasuistik mit letalem Ausgang. Anaesthesist 52(5): 419–426PubMedCrossRef

46.

Krumnikl JJ, Böttiger BW, Strittmatter HJ, Motsch J (2002) Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage. Acta Anaesthesiol Scand 46(9): 1168–1170PubMedCrossRef

47.

Ku DH, Arkel YS, Paidas MP, Lockwood CJ (2003) Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 90(6): 1074–1079PubMed

48.

Letsky EA (2001) Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15(4): 623–644 reviewPubMedCrossRef

49.

Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy and the risk of thrombo-embolic complications. Thromb Haemost 70(2): 238–240PubMed

50.

Lockwood CJ (2006) Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49(4): 836–843PubMedCrossRef

51.

Maternal Mortality Update (2002) A focus on emergency obstetric care: United Nations Population Fund

52.

Ojala K, Perala J, Kariniemi J et al. (2005) Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 84(11): 1075–1080PubMedCrossRef

53.

Orlikowski CEP, Rocke DA, Murray WB et al. (1996) Thromboelastographychanges in pre-eclampsia and eclampsia. Br J Anaesth 77: 157–161PubMed

54.

Parnas M, Sheiner E, Shoham-Vardi I et al. (2006) Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128(1–2): 163–168

55.

Pelage JP, Le Dref O, Jacob D et al. (1999) Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 78: 698–703PubMedCrossRef

56.

Pfanner G, Kilgert K (2006) Geburtshilfliche Blutungskomplikationen Hämostaseologie 26(Suppl 1): S56–S63

57.

Poe MF (1959) Clot observation test for clinical diagnosis of clotting defects. Anesthesiology 20: 825–829PubMedCrossRef

58.

Prabu P, Parapia LA (2006) Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol 28(3): 198–201PubMedCrossRef

59.

Ramanathan J, Bennett K (2003) Pre-eclampsia: fluids, drugs and anesthetic management. Anesthesiol Clin North America 21(1): 145–163PubMedCrossRef

60.

Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46(6): 1243–1249PubMedCrossRef

61.

Roberts HR, Monroe DM, Oliver JA et al. (1998) Newer concepts of blood coagulation. Haemophilia 4(4): 331–334PubMedCrossRef

62.

Rouse DJ, MacPherson C, Landon M et al. (2006) National institute of child health and human development maternal-fetal medicine units network. Blood transfusion and cesarean delivery. Obstet Gynecol 108(4): 891–897PubMedCrossRef

63.

Schuurmans N, Mackinnin C, Lane C et al. (2000) Prevention and management of postpartum haemorrhage: J Soc Obstetricians Gynaecologists Canada 88: 271–281

64.

Segal S, Shemesh IY, Blumenthal R et al. (2003) Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 268(4): 266–267PubMedCrossRef

65.

Shafi T, Jeha MT, Black L, Al Douri M (1997) Severe acquired haemophilia a treated with recombinant factor VIIa. Br J Haematol 98(4): 910–912PubMedCrossRef

66.

Sharma SK, Philip J, Whitten CW et al. (1999) Assessment of changes in coagulation in parturients with pre-eclampsia using thromboelastography. Anesthesiology 90: 3485–3490CrossRef

67.

Silliman CC, Curtis BR, Kopko PM et al. (2007) Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109(4): 1752–1755PubMedCrossRef

68.

Smith JG, Merrill DC (2006) Oxytocin for induction of labor. Clin Obstet Gynecol 49: 594–608PubMedCrossRef

69.

Sobieszczyk S, Breborowicz GH, Platicanov V et al. (2006) Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand 85(10): 1239–1247 ReviewPubMedCrossRef

70.

Teo SB, Kanagalingam D, Tan HK, Tan LK (2008) Massive postpartum haemorrhage after uterus-conserving surgery in placenta percreta: the danger of the partial placenta percreta. BJOG 115(6): 789–792PubMedCrossRef

71.

Toy P, Popovsky MA, Abraham E et al. (2005) National heart, lung and blood institute working group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 33(4): 721–726 ReviewPubMedCrossRef

72.

Vincent J-L, Rossaint R, Riou B et al. (2006) Recommendations on the use of recombinant activated factor VII as an adjunative treatment for massive bleeding: a european perspective. Crit Care 10: 1–12CrossRef

73.

Weiner CP (1986) The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 13(4): 705–717 reviewPubMed

74.

Whitta RK, Cox DJ, Mallett SV (1995) Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 74(4): 464–468PubMedCrossRef

75.

Xenakis EM, Piper JM (1997) Chemotherapeutic induction of labour. A rational approach. Drugs 54: 61–68PubMedCrossRef

76.

Yang J et al. (2005) Predictors of vaginal bleeding during the first two trimesters of pregnancy. Paediatr Perinat Epidemiol 19(4): 276–283PubMedCrossRef

77.

Zelop CM, Harlow BL, Frigoletto FD (1993) Emergency peripartum hysterectomy. Am J Obstet Gynecol 168: 1443–1448PubMed

Titel: Blutungen während Schwangerschaft und Geburt
Schwangerschaftsbedingte hämostaseologische Veränderungen – Therapieempfehlungen
verfasst von: Dr. S. Hofer
B. Heindl
F.C. Meister
H. Maul
E. Martin
C. Sohn
M.A. Weigand
Publikationsdatum: 01.01.2009
Verlag: Springer-Verlag
Erschienen in: Die Gynäkologie / Ausgabe 1/2009
Print ISSN: 2731-7102
Elektronische ISSN: 2731-7110
DOI: https://doi.org/10.1007/s00129-008-2246-1

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Blutungen während Schwangerschaft und Geburt

Schwangerschaftsbedingte hämostaseologische Veränderungen – Therapieempfehlungen

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Endokrinopathien als Ursachen habitueller Aborte

Maßnahmen zur Empfängnisverhütung: Umsatzsteuerpflicht

Thrombophile Gerinnungsstörungen als Risikofaktoren für habituelle Aborte

Endometriose und Infertilität

Psychische Faktoren bei habituellen Aborten

Schwangerschaft und maternales Immunsystem

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Update Gynäkologie